Sumitomo Pharma shares plunge nearly 16% despite greenlight for Parkinson's treatment
Post date: 2026-02-20 20:43:50
Views: 0
Shares of Japan's Sumitomo Pharma fell over 15% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.
Please click Here to read the full story.
 
Other Top and Latest Questions:
Star Trek: Starfleet Academy: Ko'Zeine
Quick Winter Getaway in Murphys, CA – any recs?
New York Gov. Hochul drops robotaxi service proposal for outside NYC in blow to Waymo
Democrats pick Virginia Gov. Spanberger to give State of the Union rebuttal
Is there a list of US TV Channels and Sub-channels?
Water in the wheels go round and round
Diversions for when you can't sit
Book: The Light Eaters
Trump to decide whether to attack Iran in next 10 days — oil prices rise
Nvidia is in talks to invest up to $30 billion in OpenAI, source says